29th Annual Conference on Mammography and Other Breast Imaging

Saturday October 14, 2017

This conference has already taken place.

The Melville Marriott Hotel - Melville, NY
1 Day Conference October 14th, 2017
7.50 AMA PRA Category 1 Credit Hours


Radiologists and technologists will jointly attend the sessions which will focus on important areas of shared responsibility and will promote dialogue between the registrants and faculty regarding problems encountered
in the practice setting.

To Register for this conference, please use the following link:


ASRT has approved this conference for 9 Category A Credits.

Dates and Times

Start: 10/14/2017 7:00 AM
End: 10/14/2017 5:00 PM


  • Compare and contrast image acquisition techniques for standard digital mammography vs breast tomosynthesis.
  • Outline expected changes in cancer detection and recall rates from screening mammography after implementation of breast tomosynthesis based on clinical trials and observational studies.
  • Describe strategies for dose reduction in breast tomosynthesis.
  • Outline evidence for using tomosynthesis rather than additional conventional mammographic views for evaluation mass margins.
  • Outline approaches for biopsy of tomosynthesis findings occult on 2D mammography.
  • Outline considerations for measuring and reporting findings seen on tomosynthesis imaging.
  • Describe how axillary nodal status, tumor size and tumor grade correlate with prognosis for invasive breast cancer.
  • Outline the histologic subtypes of invasive ductal carcinoma and describe their unique imaging features.
  • Describe the clinical and imaging presentation of invasive lobular carcinoma and identify strategies that can be utilized to maximize detection of this specific malignancy.
  • Outline evidence for the in-situ to invasive carcinoma sequence in breast cancer pathogenesis.
  • Describe principles for treating DCIS in the breast based on patient and tumor characteristics.
  • Summarize arguments for and against treating LCIS.
  • Describe the performance of breast MRI for identifying additional sites of occult carcinoma in women with newly diagnosed breast cancer.
  • Describe the positive predictive value of MRI guided-biopsy for suspicious findings seen on breast MRI.
  • Outline appropriate criteria for selecting women for supplemental screening using breast MRI.
  • Identify the characteristics that safely allow a mammographic lesion to be classified as probably benign.
  • Describe the features of a solid mass seen on ultrasound that allow it to be followed as probably benign.
  • Describe features of probably benign lesions in follow up by mammography or ultrasound that should prompt biopsy.
  • List the elements used to define negligence in medical malpractice.
  • Describe the role of the medical expert in establishing the standard of care in medical malpractice litigation.
  • Outline strategies for optimizing communication and documentation in patient care.
  • Describe the role of breast density in breast cancer risk.
  • Describe the current state of breast density notification legislation.
  • Outline strategies for maximizing breast cancer detection at screening for women with dense breasts.
  • Outline current guidelines and rationale for mammographic screening put forward by the United States Preventative Services Task Force.
  • Outline current guidelines and rationale for mammographic screening put forward by the American Cancer Society.
  • Outline strategies for using performance benchmarks from tomosynthesis implementation to address concerns for harm/benefit analysis in mammographic screening in clinical practice.


Tier Price
Physicians $235.00
Residents, Radiologic Technologists and Other Health Professionals $215.00
Physicians Late Fee - Registration at the Door $285.00

Conference Files

File Link

29th Annual Conference on Mammography and Other Breast Imaging




  • Dr. Elizabeth Rafferty
    • Breast Density: Fact, Fiction and Reality
    • Breast MRI: Screening and Diagnostic Applications
    • Breast Tomosynthesis: Approach to the Diagnostic Evaluation
    • Breast Tomosynthesis: Current State of the Art
    • Current Screening Guidelines: Can Tomosynthesis Shift the Equation?
    • Medical Malpractice in Breast Imaging: Can You Reduce Your Risk?
    • Multimodality Imaging: DCIS
    • Multimodality Imaging: Invasive Carcinoma
    • Probably Benign Finding: Mammography, Ultrasound and MRI
    • Questions and Answers


The Melville Marriott Hotel
1350 Whitman Road
Melville, NY 11747


The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credit(s) . Physicians should only claim the credit commensurate with the extent of their participation in the activity.